Super Micro Says AI Demand Is So Strong It Blew Past Its Own Forecast by 25%
π SMCI raised its fiscal Q1 revenue forecast midpoint to $19 billion, a 27% increase over prior guidance and significantly above analyst expectations.
π° Gross margin guidance was lifted to 12.0%-12.5%, up from the previous 10.4%-10.8% range, driven by favorable customer and product mix.
π The company attributed the revenue beat primarily to increased demand for AI platforms, with actual results expected to differ materially from preliminary estimates.
β οΈ Operating cash flow remains negative at -$6.81 billion for fiscal 2026 due to significant inventory buildup.
π An export-control board review regarding specific transactions remains open as the company heads into its November 3 earnings report.
π The stock closed up 15.54% in after-hours trading but is still down 41.01% over the past year from its 52-week high.
π€ Peers including Dell, HPE, and NVIDIA rose on the news, signaling broader sector strength in AI infrastructure demand.
π Super Micro named Mark Long as CFO nearly two years after beginning the search for a permanent replacement.
- Revenue forecast midpoint raised to $19 billion, representing a 26.7% increase over the previous guidance and beating analyst estimates.
- Gross margin guidance lifted to 12.0%-12.5%, significantly above the Reuters-surveyed analyst expectation of 10.15%.
- Stock surged 15.54% in after-hours trading following the earnings beat, reflecting strong market reaction to the revenue surprise.
- Revenue growth driven by increased demand for AI platforms validates the company's strategic focus on high-growth infrastructure.
- Operating cash flow was negative $6.81 billion for fiscal 2026, primarily due to a large inventory build.
- An export-control board review regarding specific transactions remains open, creating regulatory uncertainty heading into the November report.
- Auditor has not yet audited, reviewed, or compiled the preliminary revenue estimates, introducing potential accounting risk.
- Management explicitly warned that actual results may differ materially from the unaudited guidance provided.